Expansion of a peripheral blood perforin+ CD8+ T-cell subset in long-term surviving lung transplanted patients.
Berthou
C
C
INSERM U 93, Hôpital St Louis, Paris, France.
Legros-Maïda
S
S
Soulié
A
A
Wargnier
A
A
Guillet
J
J
Lafaurie
C
C
Stern
M
M
Sasportes
M
M
Israël-Biet
D
D
D000328:Adult; D015703:Antigens, CD / Q000032:analysis; D017252:CD3 Complex / Q000032:analysis; D016827:CD8 Antigens / Q000032:analysis*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D004359:Drug Therapy, Combination; D005434:Flow Cytometry; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology / Q000276:immunology; D006085:Graft Survival / Q000276:immunology*; D016041:Heart-Lung Transplantation / Q000276:immunology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007694:Killer Cells, Natural / Q000276:immunology; D016040:Lung Transplantation / Q000276:immunology*; D008562:Membrane Glycoproteins / Q000032:analysis*; D018579:Patient Selection; D054353:Perforin; D052899:Pore Forming Cytotoxic Proteins; D012016:Reference Values; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology
D015703:Antigens, CD; D017252:CD3 Complex; D016827:CD8 Antigens; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D052899:Pore Forming Cytotoxic Proteins; D054353:Perforin